![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Beaujouan J.-C. Saffroy M. Torrens Y. Glowinski J.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.319, Iss.2, 1997-01, pp. : 307-316
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Nenan S. Germain N. Lagente V. Emonds-Alt X. Advenier C. Boichot E.
European Journal of Pharmacology, Vol. 421, Iss. 3, 2001-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
SCH 206272: a potent, orally active tachykinin NK 1 , NK 2 , and NK 3 receptor antagonist
By Anthes J.C. Chapman R.W. Richard C. Eckel S. Corboz M. Hey J.A. Fernandez X. Greenfeder S. McLeod R. Sehring S. Rizzo C. Crawley Y. Shih N.-Y. Piwinski J. Reichard G. Ting P. Carruthers N. Cuss F.M. Billah M. Kreutner W. Egan R.W.
European Journal of Pharmacology, Vol. 450, Iss. 2, 2002-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Activity of SR 142801 at peripheral tachykinin receptors
By Patacchini R. Bartho L. Holzer P. Maggi C.A.
European Journal of Pharmacology, Vol. 278, Iss. 1, 1995-05 ,pp. :